177Lu-DOTATATE: comparative study between 177Lu NRG/Netherlands and 177Lu ORNL/USA

被引：0
|
作者：
Caldeira Filho, Jose de Souza [1 ]
机构：
[1] IPEN CNEN SP, Sao Paulo, Brazil
来源：
NUCLEAR MEDICINE AND BIOLOGY | 2010年 / 37卷 / 06期
关键词：
D O I：
10.1016/j.nucmedbio.2010.04.030
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：691 / 692
页数：2
相关论文
共 50 条
  • [11] Activity standardisation of 177Lu
    Nedjadi, Youcef
    Juget, Frederic
    Duran, M. Teresa
    Desorgher, Laurent
    Bochud, Francois
    Bailat, Claude
    [J]. APPLIED RADIATION AND ISOTOPES, 2023, 200
  • [12] Identification of [177Lu]Lu-PSMA I&T, [177Lu]LuCl3 and [177Lu] Lu-DTPA by a single reversed-phase TLC
    Cucchi, C.
    Bogni, A.
    Mainente, M.
    Beretta, C.
    Kirienko, M.
    Seregni, E.
    Pascali, C.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S666 - S666
  • [13] RADIOPHARMACEUTICAL TREATMENTS AND HTA: THE CASE OF [177LU]-DOTATATE
    Garagiola, E.
    Ferrario, L. B.
    Bagni, O.
    Grana, C. M.
    Lastoria, S.
    Pellerito, R. E.
    Salgarello, M.
    Seregni, E.
    Severi, S.
    Storto, G.
    Versari, A.
    Foglia, E.
    [J]. VALUE IN HEALTH, 2022, 25 (01) : S184 - S184
  • [14] Practical kidney dosimetry in peptide receptor radionuclide therapy using [177Lu]Lu-DOTATOC and [177Lu]Lu-DOTATATE with focus on uncertainty estimates
    Staanum, Peter Frohlich
    Frellsen, Anders Floor
    Olesen, Marie Louise
    Iversen, Peter
    Arveschoug, Anne Kirstine
    [J]. EJNMMI PHYSICS, 2021, 8 (01)
  • [15] Intricacies in the Preparation of Patient Doses of [177Lu]Lu-Rituximab and [177Lu]Lu-Trastuzumab Using Low Specific Activity [177Lu]LuCl3: Methodological Aspects
    Chakraborty, Avik
    Mitra, Arpit
    Sahu, Sudeep
    Tawate, Megha
    Lad, Sangita
    Kamaldeep
    Rakshit, Sutapa
    Bannore, Trupti Upadhye
    Gaikwad, Sujay
    Dhotre, Geetanjali
    Ray, Mukti Kanta
    Damle, Archana
    Basu, Sandip
    Banerjee, Sharmila
    [J]. MOLECULAR IMAGING AND BIOLOGY, 2024, 26 (01) : 61 - 80
  • [16] Intricacies in the Preparation of Patient Doses of [177Lu]Lu-Rituximab and [177Lu]Lu-Trastuzumab Using Low Specific Activity [177Lu]LuCl3: Methodological Aspects
    Avik Chakraborty
    Arpit Mitra
    Sudeep Sahu
    Megha Tawate
    Sangita Lad
    Sutapa Kamaldeep
    Trupti Rakshit
    Sujay Upadhye Bannore
    Geetanjali Gaikwad
    Mukti Kanta Dhotre
    Archana Ray
    Sandip Damle
    Sharmila Basu
    [J]. Molecular Imaging and Biology, 2024, 26 : 61 - 80
  • [17] Practical kidney dosimetry in peptide receptor radionuclide therapy using [177Lu]Lu-DOTATOC and [177Lu]Lu-DOTATATE with focus on uncertainty estimates
    Peter Frøhlich Staanum
    Anders Floor Frellsen
    Marie Louise Olesen
    Peter Iversen
    Anne Kirstine Arveschoug
    [J]. EJNMMI Physics, 8
  • [18] Administration of 177Lu-PSMA-617 as Compared to 177Lu-Dotatate
    Patel, P.
    McCall, K.
    [J]. MEDICAL PHYSICS, 2022, 49 (06) : E811 - E812
  • [19] Effects of adding an albumin binder chain on [177Lu]Lu-DOTATATE
    Rousseau, Etienne
    Lau, Joseph
    Zhang, Zhengxing
    Uribe, Carlos F.
    Kuo, Hsiou-Ting
    Zhang, Chengcheng
    Zeisler, Jutta
    Colpo, Nadine
    Lin, Kuo-Shyan
    Benard, Francois
    [J]. NUCLEAR MEDICINE AND BIOLOGY, 2018, 66 : 10 - 17
  • [20] Comparison of biological properties of [177Lu]Lu-ProBOMB1 and [177Lu]Lu-NeoBOMB1 for GRPR targeting
    Rousseau, Etienne
    Lau, Joseph
    Zhang, Zhengxing
    Zhang, Chengcheng
    Kwon, Daniel
    Uribe, Carlos F.
    Kuo, Hsiou-Ting
    Zeisler, Jutta
    Bratanovic, Ivica
    Lin, Kuo-Shyan
    Benard, Francois
    [J]. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2020, 63 (02): : 56 - 64
12345